ACME UNITED CORP

Explore ACME United’s insider selling trends—Brian Olshan’s moves signal liquidity strategy, not weakness, amid strong fundamentals and growth.

Acme United insider Rex Davidson’s quick buy‑sell on Aug. 5–10 hints at short‑term play amid CEO bullish moves, shaping investor strategy.

Acme United insider sales: COO Brian Olschan’s recent 4,833‑share sale at $42 shows routine liquidity, not panic, while the company’s AU‑101, AU‑202, AU‑303 drug programs move toward key FDA milestones—watch how these trades and clinical progress sh…

Acme United’s insider moves: COO Brian Olschan’s mixed buy‑sell trades reveal confidence and short‑term liquidity needs, yet little impact on market value.